LABCORP HOLDINGS INC. — Director's Dealing 2021

Nov 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-11-05

Reporting Person: Caveney Brian J (EVP, President of Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-05	Common Stock	M	2010	—	Acquired	10080.5271	Direct
2021-11-05	Common Stock	F	899	$274.84	Disposed	9181.5271	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-05	Restricted Stock Unit	$	M	2010	Disposed		Common Stock (2010)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 69.3574 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 5, 2020.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.